Both TNBC and HER2‐positive tumors have been recently recognized as being lymphocyte‐rich and are accompanied by abundant tumor‐infiltrating lymphocytes (TILs), also referred to as tumor‐infiltrating immune cells (ICs). The gene discussed is ERBB2; the disease is neoplasm.